Command Palette

Search for a command to run...

Clinical Trials · NCT07387796

Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation

Phase
N/A
Recruitment status
Recruiting
Sponsor
The University of Texas at Dallas
Enrollment
40
Start date
Jun 2026
Locations
1 site, United States
Primary endpoint
Change From On-Treatment to Discontinuation and Re-Initiation in Food Cue-Evoked BOLD Response in Reward and Salience Brain Regions
View Tirzepatide compound reference